irinotecan has been researched along with Rhabdomyolysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fanucchi, MP; Giblin, J; Khuri, F; Richards, S; Umbreit, JN | 1 |
1 other study(ies) available for irinotecan and Rhabdomyolysis
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Citalopram; Depressive Disorder; Drug Interactions; Gastrointestinal Neoplasms; Humans; Irinotecan; Male; Rhabdomyolysis; Selective Serotonin Reuptake Inhibitors | 2003 |